Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilo Jimenez

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcomaCamilo Jimenez, Ying Yang, Hyung-Woo Kim, et al.
Clinical Nuclear Medicine|April 17, 2024
High-Specific-Activity 131 I-MIBG for the Treatment of Advanced Pheochromocytoma and ParagangliomaRuaa Al-Ward, Vania Balderrama Brondani, Sahar Sawani, et al.
Journal of the American College of Surgeons|April 6, 2011
Posterior retroperitoneoscopic adrenalectomy: a contemporary American experiencePaxton V Dickson, Camilo Jimenez, Gary B Chisholm, et al.
The Journal of Clinical Endocrinology and Metabolism|September 14, 2013
The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2Sonali Thosani, Montserrat Ayala-Ramirez, Lynn Palmer, et al.
Cancer|March 18, 2011
Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center ExperienceShamim Ejaz, Rena Vassilopoulou-Sellin, Naifa L Busaidy, et al.
Annals of Surgery|March 4, 2017
Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic ParagangliomaAlejandro Roman-Gonzalez, Shouhao Zhou, Montserrat Ayala-Ramirez, et al.
European Journal of Endocrinology|August 19, 2008
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trialsCamilo Jimenez, Pia Burman, Roger Abs, et al.
The Lancet. Oncology|April 12, 2024
Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trialCamilo Jimenez, Mouhammed Amir Habra, Matthew T Campbell, et al.
Thyroid : Official Journal of the American Thyroid Association|December 4, 2024
Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid CarcinomaSarah Hamidi, Sireesha Yedururi, Mimi I Hu, et al.
The Oncologist|April 16, 2014
Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancerRamona Dadu, Steven G Waguespack, Steven I Sherman, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcomaCamilo Jimenez, Ying Yang, Hyung-Woo Kim, et al.
Clinical Nuclear Medicine|April 17, 2024
High-Specific-Activity 131 I-MIBG for the Treatment of Advanced Pheochromocytoma and ParagangliomaRuaa Al-Ward, Vania Balderrama Brondani, Sahar Sawani, et al.
Journal of the American College of Surgeons|April 6, 2011
Posterior retroperitoneoscopic adrenalectomy: a contemporary American experiencePaxton V Dickson, Camilo Jimenez, Gary B Chisholm, et al.
The Journal of Clinical Endocrinology and Metabolism|September 14, 2013
The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2Sonali Thosani, Montserrat Ayala-Ramirez, Lynn Palmer, et al.
Cancer|March 18, 2011
Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center ExperienceShamim Ejaz, Rena Vassilopoulou-Sellin, Naifa L Busaidy, et al.
Annals of Surgery|March 4, 2017
Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic ParagangliomaAlejandro Roman-Gonzalez, Shouhao Zhou, Montserrat Ayala-Ramirez, et al.
European Journal of Endocrinology|August 19, 2008
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trialsCamilo Jimenez, Pia Burman, Roger Abs, et al.
The Lancet. Oncology|April 12, 2024
Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trialCamilo Jimenez, Mouhammed Amir Habra, Matthew T Campbell, et al.
Thyroid : Official Journal of the American Thyroid Association|December 4, 2024
Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid CarcinomaSarah Hamidi, Sireesha Yedururi, Mimi I Hu, et al.
The Oncologist|April 16, 2014
Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancerRamona Dadu, Steven G Waguespack, Steven I Sherman, et al.
Pageof 15